NUSCO SPA (NUS.MI) Fundamental Analysis & Valuation

BIT:NUS • IT0005453110

Current stock price

0.53 EUR
+0.01 (+1.92%)
Last:

This NUS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. NUS.MI Profitability Analysis

1.1 Basic Checks

  • NUS had negative earnings in the past year.
  • NUS had a positive operating cash flow in the past year.
  • NUS had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: NUS reported negative operating cash flow in multiple years.
NUS.MI Yearly Net Income VS EBIT VS OCF VS FCFNUS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

  • The Return On Assets of NUS (-1.28%) is worse than 90.00% of its industry peers.
  • Looking at the Return On Equity, with a value of -2.96%, NUS is doing worse than 85.00% of the companies in the same industry.
  • NUS's Return On Invested Capital of 1.68% is on the low side compared to the rest of the industry. NUS is outperformed by 80.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NUS is below the industry average of 7.51%.
Industry RankSector Rank
ROA -1.28%
ROE -2.96%
ROIC 1.68%
ROA(3y)2.31%
ROA(5y)1.38%
ROE(3y)5.41%
ROE(5y)3.13%
ROIC(3y)5.35%
ROIC(5y)4.03%
NUS.MI Yearly ROA, ROE, ROICNUS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

  • In the last couple of years the Profit Margin of NUS has grown nicely.
  • NUS's Operating Margin of 2.27% is on the low side compared to the rest of the industry. NUS is outperformed by 80.00% of its industry peers.
  • NUS's Operating Margin has declined in the last couple of years.
  • The Gross Margin of NUS (40.90%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of NUS has declined.
Industry RankSector Rank
OM 2.27%
PM (TTM) N/A
GM 40.9%
OM growth 3Y5.79%
OM growth 5Y-4.26%
PM growth 3Y9.01%
PM growth 5Y9.59%
GM growth 3Y7.06%
GM growth 5Y-2.06%
NUS.MI Yearly Profit, Operating, Gross MarginsNUS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NUS.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUS is destroying value.
  • NUS has about the same amout of shares outstanding than it did 1 year ago.
  • NUS has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NUS has been reduced compared to a year ago.
NUS.MI Yearly Shares OutstandingNUS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NUS.MI Yearly Total Debt VS Total AssetsNUS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • NUS has an Altman-Z score of 1.37. This is a bad value and indicates that NUS is not financially healthy and even has some risk of bankruptcy.
  • NUS has a worse Altman-Z score (1.37) than 80.00% of its industry peers.
  • A Debt/Equity ratio of 0.24 indicates that NUS is not too dependend on debt financing.
  • The Debt to Equity ratio of NUS (0.24) is better than 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 1.37
ROIC/WACC0.28
WACC6.05%
NUS.MI Yearly LT Debt VS Equity VS FCFNUS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

2.3 Liquidity

  • NUS has a Current Ratio of 1.67. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
  • NUS's Current ratio of 1.67 is fine compared to the rest of the industry. NUS outperforms 70.00% of its industry peers.
  • A Quick Ratio of 1.17 indicates that NUS should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.17, NUS is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.17
NUS.MI Yearly Current Assets VS Current LiabilitesNUS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NUS.MI Growth Analysis

3.1 Past

  • NUS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -128.88%.
  • The Earnings Per Share has been growing by 24.44% on average over the past years. This is a very strong growth
  • NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.48%.
  • Measured over the past years, NUS shows a very strong growth in Revenue. The Revenue has been growing by 21.43% on average per year.
EPS 1Y (TTM)-128.88%
EPS 3Y28.29%
EPS 5Y24.44%
EPS Q2Q%-116.98%
Revenue 1Y (TTM)-15.48%
Revenue growth 3Y27.23%
Revenue growth 5Y21.43%
Sales Q2Q%-6.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUS.MI Yearly Revenue VS EstimatesNUS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M

More info and screens

Find the best growth stocksShow best growing peers

0

4. NUS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • NUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUS.MI Price Earnings VS Forward Price EarningsNUS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • NUS's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.68
NUS.MI Per share dataNUS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NUS.MI Dividend Analysis

5.1 Amount

  • No dividends for NUS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NUS.MI Fundamentals: All Metrics, Ratios and Statistics

NUSCO SPA

BIT:NUS (3/23/2026, 7:00:00 PM)

0.53

+0.01 (+1.92%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.71%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.57M
Revenue(TTM)49.52M
Net Income(TTM)-791.70K
Analysts80
Price Target1.63 (207.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-27.27%
PT rev (3m)-27.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF 4.38
P/B 0.4
P/tB 0.48
EV/EBITDA 6.68
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.12
OCFY22.84%
SpS2.48
BVpS1.34
TBVpS1.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.28%
ROE -2.96%
ROCE 3.12%
ROIC 1.68%
ROICexc 1.74%
ROICexgc 2.03%
OM 2.27%
PM (TTM) N/A
GM 40.9%
FCFM N/A
ROA(3y)2.31%
ROA(5y)1.38%
ROE(3y)5.41%
ROE(5y)3.13%
ROIC(3y)5.35%
ROIC(5y)4.03%
ROICexc(3y)5.81%
ROICexc(5y)4.37%
ROICexgc(3y)7.26%
ROICexgc(5y)5.4%
ROCE(3y)9.93%
ROCE(5y)7.49%
ROICexgc growth 3Y19.53%
ROICexgc growth 5Y4.04%
ROICexc growth 3Y18.73%
ROICexc growth 5Y1.56%
OM growth 3Y5.79%
OM growth 5Y-4.26%
PM growth 3Y9.01%
PM growth 5Y9.59%
GM growth 3Y7.06%
GM growth 5Y-2.06%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 2.05
Cap/Depr 279.96%
Cap/Sales 11.12%
Interest Coverage 250
Cash Conversion 78.11%
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.17
Altman-Z 1.37
F-Score4
WACC6.05%
ROIC/WACC0.28
Cap/Depr(3y)426.48%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.45%
Cap/Sales(5y)19.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.88%
EPS 3Y28.29%
EPS 5Y24.44%
EPS Q2Q%-116.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.48%
Revenue growth 3Y27.23%
Revenue growth 5Y21.43%
Sales Q2Q%-6.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-79.02%
EBIT growth 3Y34.59%
EBIT growth 5Y16.25%
EBIT Next Year83.08%
EBIT Next 3Y33.97%
EBIT Next 5YN/A
FCF growth 1Y89.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.48%
OCF growth 3YN/A
OCF growth 5YN/A

NUSCO SPA / NUS.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NUSCO SPA?

ChartMill assigns a fundamental rating of 2 / 10 to NUS.MI.


What is the valuation status of NUSCO SPA (NUS.MI) stock?

ChartMill assigns a valuation rating of 0 / 10 to NUSCO SPA (NUS.MI). This can be considered as Overvalued.


What is the profitability of NUS stock?

NUSCO SPA (NUS.MI) has a profitability rating of 2 / 10.


How financially healthy is NUSCO SPA?

The financial health rating of NUSCO SPA (NUS.MI) is 4 / 10.